welcome to van
Rooijen & Partners.
We help in creating value and maintaining success of
pharmaceutical,
biotech,
med-tech,
high-tech and
venture capital companies.
We consult, support and deliver in:
Visit our
team, look at a selection of our
clients, see the
news and feel
free to look around on our recently updated web-site.
To optimally serve our clients van Rooijen & Partners can access an active network in the relevant industries. Examples include:
3 B Scientific 3-Dimensional Pharmaceuticals 3i 3M Health Care 3M Medica 4SC Abbott Abingworth Management Ablynx ABN AMRO Participaties ABN AMRO Rothschild Access Capital Partners Across Barriers ACT Unternehmensberatung Actelion Ltd. AdAstra Venture Adisseo ADL Adnagen Adobe Ventures Advent International Aerovance Aesculap Affimed Therapeutics Affinium Pharmaceuticals Affymetrix Agilent Technologies Akzo Nobel Alafi Capital AlcaSynn Pharmaceuticals Alcatel Alchemy Alcon Pharma Alice Ventures Aliga Pharmaceuticals Aliud Pharma Allegiance Health Care Allergan Allergopharma Allianz Private Equity Partners Allianz Venture Partners Alpharma Isis Alta Partners Alta-Berkeley Associates Altana Innovationsfond Altana Pharma Amersham Biosciences Amersham Buchler Amersham Pharmacia Biotech Amgen AM-Pharma Amphion Capital Partners Anthos Antisense Pharma Anzag AP Celera Apax Partners Applera Applied Biosystems Artemis Artemis Pharmaceutical ARTHOS corporate finance Arthur Andersen Corporate Finance Arzneimittel Werk Dresden AS Venture ascenion Asche Asinex Aspen Ventures Aspiras Astra Zeneca Atid Pharma Atila Ventures Atlas Venture Aurelia Private Equity Auriga AUSTRIANOVA Biotechnology Avantium Technologies Avecia Biologics Avida Equity Partners Avlar BioVentures Ltd. Axa Private Equity Axa Venture Fund Axaron Bioscience Axiogenesis Axxima Pharmaceutical Azupharma B. Braun Medical B. Braun Melsungen Baden Württembergische Bank Banexi Ventures Partners Bank Vontobel BankInvest Barclays Private Equity BASF BASF Agrochemical Basics Basilea Pharmaceutica Baxter Bayer Bayer Crop Science Bayer Diagnostics Bayer Innovation Bayer Technology Services Bayer Vital Bayern Kapital Baytech Venture Capital BC Brandenburg Capital Bear Stearns Health Innoventures Beaufort Capital Becton Dickinson Behringwerke Beiersdorf Berlin Chemie betapharm Arzneimittel BHF Private Equity Bio Fund Management Biobase Bioforce Biofrontera Pharmaceuticals Biogen Idec BioGenerix AG BioImmunPharma Loh Biolex Biologische Heilmittel Heel Bio-M BioMarin Pharmaceutical BioMed Venture BioMedinvest BioMerieux Bio-Rad Laboratories Bioscience Ventures Group biosyn Arzneimittel Biotechnology Application Centre Biotest Pharma biovitrum Boehringer Ingelheim Boston Scientific Bristol Myers Squibb Brockhaus Private Equity Burrill & Company BW Venture Byk Gulden BZT CAM Private Equity Cambridge Antibody Technlogy Capital Stage Capital Z Partners Capsulution NanoScience Cardion Care Capital CD-Venture GmbH Cell Center Cologne Cell Pharm Cell Pharma Cellectricon AB Cellzome Centurion Capital Ceva Chemical Diversity Labs Chiron Behring Ciba Vision Cilian CMEA Ventures Concord Venture Management Creathor Venture Credit Suisse ct Arzneimittel Curacyte CureVac cytos biotechnology Dansk Kapitalanlaeg Aktieselskab DCapS Debio Pharm Decode Genetics Degussa Dentsply De Trey Desitin Deutsche Bank Deutsche Venture Capital Develogen Devgen DEWB DHU Dolorgiet Dr. Kade Dr. Neuhaus Techno Nord Dr. Suwelack Skin & Health Care Dr. Willmar Schwabe DSM Biologics DuPont Pharma Earlybird Venture Capital Elan Pharma elbion Eli Lilly EMBL Technology Fund Endo Pharmaceuticals Entrepreneurs Fund Equity4Health ESPE Dental AG Essex Pharma Ethicon Euclid SR ONE Eurogentec European Investment Fund EVOTEC BioSystems Evotec Neurosciences Evotec OAI F.Hoffmann-La Roche Faust Pharma Ferring First Ventury Fluorotronics Fluorous Technologies flyion Fontile Fort Dodge Veterinär Fournier Pharma Fresenius Fujisawa Fulcrum Future Capital G. Pohl Boskamp Gamma Capital Garching Innovation GE Healthcare Genavent Genentech Genzyme Gilde Investment Management GIMV Glaxo Wellcome GlaxoSmithKline Global Genomics Global Life Science Ventures Global Vision GPC Biotech Grünenthal GRY Pharma Haemato-basics Haupt Pharma HBM BioVentures HBM Partners HealthCap Odlander, Fredrikson Heart BioSystems Heidelberg Innovation Heidelberg Pharma HeLaBa Henkel Henkel VTV Corporate Research Ventures Hennig Arzneimittel Hermal Kurt Herrmann Hexal High Tech Private Equity Hoffmann La Roche Honeywell Specialty Chemicals Hopp Capital Horizonte Venture Management Hormosan Kwizda Hoyer Madaus Human Genome Sciences Hybrigenics Hybrigenics IBB Idea IKB Private Equity Immuno Designed Molecules Index Ingenium Pharmaceuticals Innogenetics innovatis inova Intercell InterComponentWare Invesco Asset Management Invest Equity Investitionsbank Hessen IonGate Biosciences Italfarmaco Janssen Cilag Janssen Pharmaceutica Jenapharm Jerini Johnson & Johnson KeyNeurotek King Pharmaceuticals Klinge Pharma Knoll Kuros Therapeutics Kyorin Pharmaceuticals Kyowa Hakko Kogyo Laboratoire Zambon LensWista Leo Pharma Leonardo Venture Lichtwer Pharma Life Science Partners Lilly Lombard Odier & Cie Lonza L'Oreal Madaus Max Planck Institutes medimod Merck Merck & Co. Merck dura Merck Sharp & Dohme Merckle Merial Merlin Biosciences Merz Pharma Millennium Pharmaceuticals Morley Fund Management Morphochem MPM Capital MUCOS Pharma Mundipharma Nanogen NascaCell Nestlé Neuraxo Neuro 3d Neuronova NeuroNova NeuroVentures Capital Newron Pharamceuticals NGN Capital Nomura International Novartis Consumer Health Novartis Pharmaceuticals Novartis Venture Fund novo nordisk Nycomed Pharma Octo+Plus Oral B Laboratories Organon Orion Pharma Ortho Clinical Diagnostics Oxford Bioscience Partners Paion Parexel Paul Capital Partners Paul Hartmann Peppermint Financial Partners Pfizer Pfrimmer Nutricia Pharm Allergan Pharmacia & Upjohn PharmaVend Pictet & Cie Pierre Fabre Pharma PlantTec PlasmidFactory PolyTechnos Venture-Partners Prelude Technology Investments Prelude Ventures PriCap Prionics Pro Generika Procter & Gamble Prokaria ProQinase Proteome Sciences ProteoSys Qiagen Quintiles Ratiopharm Rentschler-Arzneimittel responsif gmbh RhoxalPharma Roche Diagnostics Rotta Research Laboratorium Sachsen LB Corporate Finance Sanders Morris Harris Sandoz Pharmaceuticals Sankyo Pharma Sanofi Ceva Sanofi-Aventis SB Pharma Schering Schroder Ventures Schwarz Pharma Scientific Generics Scil Biomedicals Seed Serono Servier SHS Siegfried Siemens Venture Capital Sirenade SmithKline Beecham Sofinnova Solvay Pharmaceuticals St Charles Pharmaceuticals Stada Star Venture Management Supremol TechnoStart Teva Generics The genetics company TNO Pharma TopLab Transave Triangle Venture Trommsdorff Troponwerke TVM Techno Venture Management UCB VCM Venture Capital Management Ventizz Capital Partners Vertex Pharmaceuticals Viatris wellington partners WGZ Wilex Wyeth Pharmaceuticals Xcel Pharmaceuticals Xerion Pharmaceuticals Yamanouchi Zambon ZLB Behring
van Rooijen &
Partners has the following entry sites:
|